Back to
UBS Group AG
VIVO
Showing 0 of 17 quarters
Position history for
UBS Group AG's holdings in MERIDIAN BIOSCIENCE INC
As of its Q4 2022 13F, UBS Group held 50,739 shares of VIVO (Meridian Bioscience), worth $1.7M. UBS Group's 13F filings listed VIVO from Q1 2019 to Q4 2022, 16 quarterly filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.